GoodRx Holdings: Strong Business Fundamentals and Undervalued Potential Justify Buy Rating Despite CFO Transition

TipRanksJan 15 15:14

BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Cuts Target Price to $4.25

Futu NewsJan 14 04:31

Citi Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $6.25

Futu NewsJan 10 20:34

GoodRx Holdings Is Maintained at Overweight by Keybanc

Dow JonesJan 9 04:44

GoodRx Holdings Analyst Ratings

BenzingaJan 9 04:34

RBC Capital Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $6

Futu NewsJan 9 01:31

KeyBanc Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $6

Futu NewsJan 8 20:34

KeyBanc Cuts Price Target on GoodRx Holdings to $6 From $7, Keeps Overweight Rating

MT NewswiresJan 8 20:26

Mizuho Securities Maintains GoodRx(GDRX.US) With Hold Rating

Futu NewsDec 21, 2024 02:32

TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsDec 21, 2024 02:31

Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating

Futu NewsDec 21, 2024 02:31

GoodRx Holdings: Buy Rating Reaffirmed Amid Leadership Stability and Growth Prospects

TipRanksDec 18, 2024 13:37

GoodRx Holdings Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesDec 18, 2024 01:03

GoodRx Holdings Analyst Ratings

BenzingaDec 18, 2024 00:53

Morgan Stanley Maintains GoodRx(GDRX.US) With Hold Rating, Cuts Target Price to $6

Futu NewsDec 17, 2024 22:31

Morgan Stanley Sticks to Their Hold Rating for GoodRx Holdings (GDRX)

TipRanksDec 17, 2024 21:37

Citi Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $7

Futu NewsDec 17, 2024 09:31

Wells Fargo Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $9

Futu NewsDec 17, 2024 09:31

BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Maintains Target Price $4.5

Futu NewsDec 17, 2024 09:31

Sell Rating Maintained for GoodRx Holdings Amid Volatility and Strategic Challenges

TipRanksDec 17, 2024 08:58